You can get semaglutide injections online only with a prescription from a licensed clinician. FDA-approved semaglutide injections include Wegovy and Ozempic; some clinicians may prescribe compounded semaglutide when appropriate. Chia offers clinician-reviewed access to compounded semaglutide injections from state-licensed 503A pharmacies, but eligibility and prescriptions are never guaranteed.
Wondering if semaglutide is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you get semaglutide injections online?
Yes, semaglutide injections can be prescribed through telehealth when a licensed clinician reviews your health history and decides the medication is appropriate. The key point is prescription-first access: the online visit should be medical care, not a checkout page.
What an online prescription process should include
A safer online process should ask about your height, weight, BMI, health conditions, medications, allergies, pregnancy status, and past reactions to GLP-1 medications. It should also explain common side effects, when to seek urgent care, how follow-up works, and which pharmacy will fill the prescription.
The FDA advises patients to obtain GLP-1 medications with a prescription from a clinician and fill that prescription through a state-licensed pharmacy 5. That is the basic safety line between telehealth care and unsafe no-prescription sales.
Why a licensed clinician review is required
Semaglutide affects appetite regulation, satiety, blood glucose control, and gastric emptying, which means it can also cause side effects and interact with a person’s medical risks 1. A clinician review helps screen for issues such as pregnancy, pancreatitis history, gallbladder disease, low blood sugar risk with diabetes medicines, and contraindications listed in labeling 2.
What to avoid when buying medication online
- Avoid any website that sells semaglutide without a prescription or clinician screening.
- Avoid sellers that claim compounded semaglutide is the same as Wegovy or Ozempic.
- Avoid products labeled only for “research use” or shipped without clear pharmacy labeling.
- Avoid medication that arrives damaged, unlabeled, warm when cold shipping was expected, or without instructions for use.
- Avoid self-directed dose changes; dosing and dose changes should be provider-guided.
FDA has warned about risks linked to unapproved GLP-1 products, including dosing errors, fraudulent sources, and problems with storage during shipping 5. A study of no-prescription online semaglutide sellers also found major safety concerns, including illegal sales and product-quality risks 6.
What is semaglutide and how does it work?
Semaglutide is a glucagon-like peptide-1 receptor agonist, also called a GLP-1 receptor agonist. It acts on GLP-1 receptors involved in appetite, satiety, glucose regulation, and gastric emptying 1.
Semaglutide, GLP-1 receptors, appetite, and digestion
GLP-1 is a hormone signal your body already uses after eating. Semaglutide lasts longer than natural GLP-1, so it can help people feel full sooner, reduce hunger signals, slow stomach emptying, and improve blood glucose control 1.
In the STEP 1 trial, adults with overweight or obesity received once-weekly semaglutide 2.4 mg or placebo along with lifestyle intervention; the semaglutide group had greater average weight loss than placebo 3. Individual results vary, and the studied product and dosing should not be treated as instructions for a reader. Nausea, vomiting, diarrhea, constipation, and abdominal pain are common side effects listed in semaglutide labeling 2.
Wegovy, Ozempic, and Rybelsus: brand-name semaglutide options
Wegovy is semaglutide injection labeled for chronic weight management and cardiovascular risk reduction in certain adults; Ozempic is semaglutide injection labeled for type 2 diabetes and certain cardiovascular and kidney risk uses; Rybelsus is oral semaglutide labeled for type 2 diabetes 1, 2, 7, 8. These products are not interchangeable without clinician guidance.
Why semaglutide is used for weight management and type 2 diabetes
Semaglutide can lower appetite and support blood glucose control, which is why it is used in different FDA-approved products for obesity, overweight with certain health risks, and type 2 diabetes mellitus 1. These benefits must be balanced with risks, including gastrointestinal side effects, gallbladder problems, pancreatitis warnings, and the boxed warning in Wegovy labeling about thyroid C-cell tumors seen in rodents 2.
Do you need a prescription for semaglutide?
Yes. Semaglutide requires a prescription, whether the medication is an FDA-approved product or a compounded medication. A safe online service should require licensed clinician screening before any medication is dispensed.
Why prescription-only status matters
Prescription-only status helps make sure a clinician checks whether semaglutide fits the patient’s health profile. This matters because semaglutide can affect blood sugar and digestion, and because certain medical histories may require caution or avoidance 1, 2.
What a clinician may review before prescribing
- BMI, weight history, and weight-related health conditions such as hypertension, dyslipidemia, sleep apnea, or cardiovascular disease.
- Type 2 diabetes mellitus, current diabetes medications, and low blood sugar risk.
- History of pancreatitis, gallbladder disease, kidney problems, severe gastrointestinal disease, or thyroid cancer risk.
- Pregnancy, plans for pregnancy, breastfeeding, or fertility treatment.
- Current medications and supplements that may affect safety or tolerability.
This review is also where a clinician can explain expected benefits, side effects, contraindications, and follow-up. The FDA specifically advises patients to talk with a doctor and obtain GLP-1 medications through a prescription filled by a state-licensed pharmacy 5.
Why no-prescription semaglutide websites are a safety red flag
A site that skips medical screening cannot know whether semaglutide is safe for you. FDA lists lack of screening and prescription by a licensed doctor as a telehealth red flag, along with misleading claims, damaged packaging, missing instructions, and prices that seem too good to be true 5.
What is the difference between Wegovy, Ozempic, and compounded semaglutide?
Wegovy, Ozempic, and compounded semaglutide all involve semaglutide as an active ingredient, but they are not the same product. The most important difference is FDA approval status and product review.
| Option | Form | FDA status | Common labeled use | Key safety note |
|---|---|---|---|---|
| Wegovy | Injection | FDA-approved product | Chronic weight management in certain adults and pediatric patients; cardiovascular risk reduction in certain adults | Label includes titration, contraindications, boxed warning, and side effect information 2 |
| Ozempic | Injection | FDA-approved product | Type 2 diabetes; certain cardiovascular and kidney risk uses | Not labeled as a weight-loss drug; use should follow clinician judgment and labeling 7 |
| Rybelsus | Tablet | FDA-approved product | Type 2 diabetes | Oral semaglutide has different administration rules than injections 8 |
| Compounded semaglutide via 503A pharmacy | Depends on prescription and pharmacy preparation | Not FDA-approved | May be prescribed when a licensed clinician determines it is appropriate | Not reviewed by FDA for safety, effectiveness, or quality before marketing 5 |
FDA-approved semaglutide products
FDA-approved semaglutide products have FDA-reviewed labeling, manufacturing controls, and approved indications. Wegovy’s label includes chronic weight management use in adults with obesity or overweight with at least one weight-related condition, along with diet and physical activity 2.
Compounded semaglutide via a 503A pharmacy
Compounded semaglutide is prepared by a compounding pharmacy for a specific prescription. A compounded medication is not a generic version of Wegovy or Ozempic, and it should not be described as the same as an FDA-approved product 5.
What compounded medications can and cannot claim
Clinical trials support semaglutide as an active ingredient for certain uses, including weight management in studied populations 3, 4. But outcomes are not established for compounded formulations, because compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing 5. Side effects and contraindications still matter and should be reviewed with a clinician.
When compounded medication may be considered
A clinician may consider a compounded medication after reviewing the patient’s needs, risks, access issues, and available options. The safety focus should be licensed care: a valid prescription, a state-licensed 503A pharmacy, clear labeling, and follow-up support.
3-min quiz
Considering semaglutide online?
Chia offers clinician-reviewed access to compounded semaglutide injections, with plans currently starting at $249/month. A licensed provider reviews your health history and prescribes only when clinically appropriate; a prescription is never guaranteed. Compounded drugs are not FDA-approved.
Semaglutide injections at Chia: online clinician review and home delivery
At Chia, semaglutide injection is available through a 100% online process, with plans currently starting at $249/month. Our providers review each intake and prescribe only when clinically appropriate.
Chia’s compounded semaglutide injection offering
Chia offers compounded semaglutide as an injection. We do not list semaglutide tablets in our current catalog. For patients comparing GLP-1 options, Chia also offers tirzepatide tablets and injections, with microdosing plans available when clinically appropriate.
| Chia option | Forms listed in Chia catalog | Current starting price | Microdosing plans | How access works |
|---|---|---|---|---|
| Semaglutide | Injection | From $249/month | Available when clinically appropriate | Online intake, licensed-provider review, 503A pharmacy compounding, home delivery |
| Tirzepatide | Tablets and injection | Tablets from $249/month; injection from $299/month | Available when clinically appropriate | Online intake, licensed-provider review, 503A pharmacy compounding, home delivery |
How Chia’s online intake and licensed provider review work
You start with a short online health questionnaire. A licensed US provider reviews your answers, including health history, medications, treatment goals, and safety risks. If treatment is appropriate, the provider can prescribe; if it is not appropriate, a prescription is not issued.
Microdosing plans when clinically appropriate
Chia offers provider-guided microdosing plans for semaglutide when clinically appropriate. That does not mean every patient should start low, change doses on their own, or qualify for treatment. Dosing decisions are individualized by the provider and adjusted over time.
503A pharmacy compounding and door-to-door shipping
When prescribed through Chia, medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Injectable GLP-1 medications may require careful storage, shipping, labeling, and instructions, and the FDA has warned about problems when online sellers do not handle these steps safely 5.
Messaging your care team through the patient portal
Patients can message the Chia care team through the patient portal between visits. That matters because side effects, missed doses, dose questions, or new medications should be handled with clinical guidance rather than self-directed changes.
Some patients considering GLP-1 care also ask about supportive protocols such as Weight + Energy, which pairs NAD+ injection with a choice of GLP-1, or Weight + Muscle, which pairs sermorelin injection with a choice of GLP-1. These protocols still require clinician review, and prescriptions are not guaranteed.
Who may be eligible for semaglutide injections?
Eligibility for semaglutide depends on the person’s health profile, goals, and risks. For FDA-approved Wegovy, labeled adult weight-management criteria include obesity or overweight with at least one weight-related condition, alongside diet and physical activity 2.
Common clinical factors providers consider
- BMI and weight history.
- Weight-related health conditions, such as hypertension, dyslipidemia, sleep apnea, or cardiovascular disease.
- Type 2 diabetes mellitus and current glucose-lowering medicines.
- Prior GLP-1 use, side effects, or reasons for stopping.
- Lifestyle goals, nutrition patterns, and ability to follow up.
In clinical trials, once-weekly semaglutide 2.4 mg was studied with lifestyle intervention in adults with overweight or obesity 3. Benefits should be discussed together with risks, including nausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder problems, pancreatitis warnings, and low blood sugar risk when used with insulin or sulfonylureas 2.
Weight-related health conditions and treatment goals
A provider may ask whether weight is affecting blood pressure, cholesterol, blood sugar, joints, sleep, or heart risk. Clear goals help the provider decide whether medication, nutrition changes, activity, or another plan is the right next step.
Why eligibility cannot be guaranteed online
No online clinic should promise approval before a medical review. A patient may not qualify because of medical history, medication risks, pregnancy status, side effects, or because another treatment path is safer.
What can disqualify someone from taking semaglutide?
Semaglutide may not be appropriate for some people. A clinician must review contraindications, cautions, medications, and pregnancy status before prescribing.
Medical history that may require caution or avoidance
Wegovy labeling lists contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or serious hypersensitivity to semaglutide or product components 2. Labeling also includes warnings about pancreatitis, gallbladder disease, acute kidney injury, diabetic retinopathy complications in patients with type 2 diabetes, increased heart rate, and suicidal behavior or thinking 2.
Medication interactions and pregnancy considerations
Semaglutide can increase low blood sugar risk when used with insulin or insulin secretagogues, so diabetes medications may need clinician review 2. Wegovy labeling also advises stopping the medication at least 2 months before a planned pregnancy because of its long half-life 2.
Why a clinician should review personal risk
Risk is personal. Two people can have the same BMI but very different medical histories, medications, side effect risks, and treatment goals. That is why an online questionnaire alone is not enough; a licensed clinician must review it.
How can you tell if an online semaglutide provider is safer?
A safer provider requires clinician screening, a valid prescription, and a state-licensed pharmacy. The biggest red flag is no-prescription access.
Look for clinician screening and prescription requirements
The service should ask medical questions before payment is final, make clear that approval is not guaranteed, and give you a way to ask a licensed clinician questions. FDA lists lack of screening and prescription by a licensed doctor as a warning sign 5.
Confirm pharmacy identity and state licensure
You should know which pharmacy is dispensing your medication and whether it is state-licensed. FDA advises filling prescriptions through a state-licensed pharmacy and using safe online pharmacy resources when buying prescription medicines online 5.
Watch for FDA-listed red flags
- Claims that a compounded drug is the same as an FDA-approved drug.
- No licensed clinician screening before medicine is provided.
- No clinician available to answer questions after purchase.
- Prices that seem too good to be true.
- Broken packaging, missing instructions, or product that looks different than expected.
- Unclear storage, shipping, or labeling instructions.
Check shipping, refrigeration, and labeling instructions
Injectable medications may need temperature control, clear labeling, and plain instructions. FDA has reported concerns about dosing errors and improper storage during shipping with some unapproved GLP-1 products 5. If anything arrives damaged, unclear, or inconsistent with your instructions, contact the pharmacy or prescriber before using it.
Why is semaglutide sometimes hard to get?
Semaglutide access can be affected by demand, insurance coverage, cost, pharmacy supply, and local availability. Many patients compare options because access barriers can be real.
Demand, access, cost, and insurance barriers
FDA-approved semaglutide products may be expensive without insurance, and insurance coverage can depend on the labeled use, diagnosis, plan rules, and prior authorization. Supply and pharmacy availability can also change over time, which is one reason patients ask about telehealth and compounded options.
Why patients may compare FDA-approved and compounded options
Patients may compare FDA-approved products and compounded semaglutide because of access, cost, tolerability, or clinical fit. The comparison should be honest: FDA-approved products and compounded semaglutide are different, and compounded drugs are not FDA-reviewed before marketing 5. Side effects and contraindications should be reviewed no matter which route is used.
How to discuss access issues with a clinician
Tell the clinician what you have tried, what your insurance covers, what you can afford, and what side effects you are worried about. A good visit should help you understand realistic options, not push you toward one path before your risks are reviewed.
What should you ask before starting semaglutide online?
Before starting semaglutide online, ask about benefits, risks, dosing instructions, follow-up, pharmacy identity, and what to do if side effects happen. Good care includes ongoing support, not just a shipped vial or pen.
Questions about benefits and risks
- Why might semaglutide be appropriate or not appropriate for me?
- What side effects should I expect, and which symptoms need urgent care?
- How do my medical conditions affect risk?
- How could semaglutide affect my blood sugar, digestion, or other medications?
- What are the limits of evidence for the specific product being prescribed?
Questions about dose instructions and side effects
Ask how instructions will be written, how dose changes are handled, and who to contact before making any change. FDA has received reports of dosing errors with compounded injectable semaglutide, including errors related to measuring doses from vials 5.
Questions about follow-up care and when to seek help
Ask how often follow-up happens, how to message the care team, and when symptoms should prompt urgent care. Severe abdominal pain, persistent vomiting, signs of dehydration, allergic reaction, or symptoms of low blood sugar in people using diabetes medicines should be handled with medical guidance 2.
How do you start a semaglutide online visit with Chia?
You can start with Chia’s online eligibility quiz in a few minutes. The important part is that a licensed provider reviews your information before any prescription decision is made.
- 1Start the Chia eligibility quiz and answer health-history questions.
- 2A licensed US provider reviews your intake for clinical fit and safety.
- 3If prescribed, compounded semaglutide injection is prepared by a state-licensed 503A pharmacy.
- 4Medication is shipped to your door with instructions.
- 5You can message your care team through the patient portal for follow-up questions.
If you already know you want to compare GLP-1 options, you can read about Chia’s semaglutide injection and tirzepatide offerings before starting. If you use an AI agent to organize health tasks, Chia can also be reached through DoctorMCP at mcp.chia.health; a prescription still requires the same medical evaluation and is not guaranteed.
3-min quiz
Start with a licensed-provider review
Chia’s online visit helps our providers decide whether compounded semaglutide injection is clinically appropriate for you. Plans currently start at $249/month, and medication is shipped only if prescribed. Compounded drugs are not FDA-approved, and eligibility is never guaranteed.
Frequently asked questions
Yes. Semaglutide requires a prescription from a licensed clinician. Any online seller that offers semaglutide without medical screening or a prescription is a safety red flag.
A licensed clinician may prescribe a compounded medication when they decide it is appropriate for a specific patient. The prescription should be filled by a state-licensed pharmacy, and the patient should receive clear instructions and follow-up.
No. Compounded semaglutide is not FDA-approved and is not reviewed by FDA for safety, effectiveness, or quality before marketing. It should not be described as the same as Wegovy or Ozempic.
Yes, semaglutide injections can be shipped when prescribed and dispensed through a legitimate pharmacy process. Injectable GLP-1 medications need clear labeling, storage instructions, and a way to contact the prescriber or pharmacy with questions.
Possible reasons include certain thyroid cancer risks, serious allergy to semaglutide or ingredients, pregnancy considerations, or medical histories that make the medication higher risk, such as pancreatitis or gallbladder disease. A clinician must review your personal risk.
Semaglutide as an active ingredient has been studied for weight management, and FDA-approved Wegovy is labeled for chronic weight management in certain patients. Results are not established for compounded formulations, and side effects and contraindications must be reviewed with a clinician.
Chia’s compounded semaglutide injection plans currently start at $249 per month. Pricing can change, so the product page is the best place to check current details before starting an online visit.
Yes. If you use an AI agent for health logistics, Chia can be reached through DoctorMCP at mcp.chia.health. This does not guarantee treatment; a licensed provider still must review your information and decide whether a prescription is appropriate.
References
- 1.Collins L, Costello RA. Semaglutide. StatPearls. 2026.
- 2.Novo Nordisk. Wegovy (semaglutide) injection prescribing information. U.S. Food and Drug Administration. 2026.
- 3.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- 4.Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
- 5.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2026.
- 6.Mackey TK, Nayyar G, et al. Safety and Risk Assessment of No-Prescription Online Semaglutide Products. JAMA Network Open. 2024.
- 7.Novo Nordisk. Ozempic (semaglutide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 8.Novo Nordisk. Rybelsus (semaglutide) tablets prescribing information. U.S. Food and Drug Administration. 2024.
- 9.Singh G, Krauthamer M, Bjalme-Evans M. Wegovy (semaglutide): a new weight loss drug for chronic weight management. Journal of Investigative Medicine. 2022.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if semaglutide is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



